Literature DB >> 27894893

The blood brain barrier in Alzheimer's disease.

A Chakraborty1, N M de Wit2, W M van der Flier3, H E de Vries2.   

Abstract

Alzheimer's disease (AD) is the most common form of dementia, affecting millions of people worldwide. One of the prominent causative factors of AD pathogenesis is cerebral vascular dysfunction, which results in diminished cerebral perfusion. Moreover, due to the loss of the protective function of the blood-brain barrier (BBB), impaired clearance of excess neurotoxic amyloid beta (Aβ) occurs, causing vascular perturbation and diminished cognitive functioning. The relationship between the prevalence of AD and vascular risk factors is complex and not fully understood. In this review we illustrate the vascular risk factors, their effects on BBB function and their contributions to the onset of AD. Additionally, we discuss the underlying factors that may lead to altered neurovascular function and/or cerebral hypoperfusion in AD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; blood-brain barrier; vascular disorders

Mesh:

Substances:

Year:  2016        PMID: 27894893     DOI: 10.1016/j.vph.2016.11.008

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  19 in total

1.  Mural lymphatic endothelial cells regulate meningeal angiogenesis in the zebrafish.

Authors:  Neil I Bower; Katarzyna Koltowska; Cathy Pichol-Thievend; Isaac Virshup; Scott Paterson; Anne K Lagendijk; Weili Wang; Benjamin W Lindsey; Stephen J Bent; Sungmin Baek; Maria Rondon-Galeano; Daniel G Hurley; Naoki Mochizuki; Cas Simons; Mathias Francois; Christine A Wells; Jan Kaslin; Benjamin M Hogan
Journal:  Nat Neurosci       Date:  2017-05-01       Impact factor: 24.884

Review 2.  Mapping the collaterome for precision cerebrovascular health: Theranostics in the continuum of stroke and dementia.

Authors:  David S Liebeskind
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-30       Impact factor: 6.200

Review 3.  Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?

Authors:  Corey J Frank; Ewan C McNay
Journal:  J Neuroendocrinol       Date:  2021-12-13       Impact factor: 3.627

4.  Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury.

Authors:  Yi Yang; Shihoko Kimura-Ohba; Jeffrey F Thompson; Victor M Salayandia; Melissa Cossé; Limor Raz; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  Neurobiol Dis       Date:  2018-02-24       Impact factor: 5.996

Review 5.  Recent advances in pre-clinical diagnosis of Alzheimer's disease.

Authors:  John Zhou; Marc Benoit; Md Golam Sharoar
Journal:  Metab Brain Dis       Date:  2021-04-26       Impact factor: 3.655

Review 6.  Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective.

Authors:  Rodrigo E González-Reyes; Mauricio O Nava-Mesa; Karina Vargas-Sánchez; Daniel Ariza-Salamanca; Laura Mora-Muñoz
Journal:  Front Mol Neurosci       Date:  2017-12-19       Impact factor: 5.639

7.  Subject-specific multi-poroelastic model for exploring the risk factors associated with the early stages of Alzheimer's disease.

Authors:  Liwei Guo; John C Vardakis; Toni Lassila; Micaela Mitolo; Nishant Ravikumar; Dean Chou; Matthias Lange; Ali Sarrami-Foroushani; Brett J Tully; Zeike A Taylor; Susheel Varma; Annalena Venneri; Alejandro F Frangi; Yiannis Ventikos
Journal:  Interface Focus       Date:  2017-12-15       Impact factor: 3.906

8.  Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model.

Authors:  Julie Vérité; Guylène Page; Marc Paccalin; Adrien Julian; Thierry Janet
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

Review 9.  Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors.

Authors:  Zoë P Van Acker; Marine Bretou; Wim Annaert
Journal:  Mol Neurodegener       Date:  2019-06-03       Impact factor: 14.195

Review 10.  Current state of Alzheimer's fluid biomarkers.

Authors:  José Luis Molinuevo; Scott Ayton; Richard Batrla; Martin M Bednar; Tobias Bittner; Jeffrey Cummings; Anne M Fagan; Harald Hampel; Michelle M Mielke; Alvydas Mikulskis; Sid O'Bryant; Philip Scheltens; Jeffrey Sevigny; Leslie M Shaw; Holly D Soares; Gary Tong; John Q Trojanowski; Henrik Zetterberg; Kaj Blennow
Journal:  Acta Neuropathol       Date:  2018-11-28       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.